https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-01 / Cytotherapy 2014 Jul;16(7):934-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-01 / Cytotherapy 2014 Jul;16(7):934-452014-05-01 00:00:002014-05-01 00:00:00Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / Immunotherapy 2014;6(3):349-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / Immunotherapy 2014;6(3):349-602014-01-01 00:00:002019-02-15 08:50:00Dendritic cell-based vaccines: clinical applications in breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-11-01 / Cancer J 2013 Nov-Dec;19(6):511-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-11-01 / Cancer J 2013 Nov-Dec;19(6):511-62013-11-01 00:00:002013-11-01 00:00:00Dendritic cells, inflammation, and breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-11-01 / Gan To Kagaku Ryoho 2013 Nov;40(12):1596-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-11-01 / Gan To Kagaku Ryoho 2013 Nov;40(12):1596-92013-11-01 00:00:002013-11-01 00:00:00[The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-92013-08-01 00:00:002019-02-15 08:50:01Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-07-13 / Ann. Surg. Oncol. 2013 Oct;20(10):3233-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-07-13 / Ann. Surg. Oncol. 2013 Oct;20(10):3233-92013-07-13 00:00:002019-02-15 08:50:02Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-932013-06-03 00:00:002013-06-03 00:00:00Re-irradiation and hyperthermia after surgery for recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-832012-12-11 00:00:002012-12-11 00:00:00Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-11-01 / Gan To Kagaku Ryoho 2012 Nov;39(12):1766-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-11-01 / Gan To Kagaku Ryoho 2012 Nov;39(12):1766-92012-11-01 00:00:002012-11-01 00:00:00[Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-242012-09-01 00:00:002023-03-07 13:03:07Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
